|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2011-1-28
|
|
pubmed:abstractText |
HHT is an autosomal dominant disease with an estimated prevalence of at least 1/5000 which can frequently be complicated by the presence of clinically significant arteriovenous malformations in the brain, lung, gastrointestinal tract and liver. HHT is under-diagnosed and families may be unaware of the available screening and treatment, leading to unnecessary stroke and life-threatening hemorrhage in children and adults.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/ACVRL1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Activin Receptors, Type II,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/ENG protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Cell Surface,
http://linkedlifedata.com/resource/pubmed/chemical/SMAD4 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Smad4 Protein
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1468-6244
|
|
pubmed:author |
pubmed-author:BrownD HDH,
pubmed-author:BuscarinoCC,
pubmed-author:ChesnuttM SMS,
pubmed-author:CottinVV,
pubmed-author:FaughnanM EME,
pubmed-author:GangulyAA,
pubmed-author:Garcia-TsaoGG,
pubmed-author:GeisthoffU WUW,
pubmed-author:GossageJ RJR,
pubmed-author:GuttmacherA EAE,
pubmed-author:HHT Foundation International - Guidelines Working Group,
pubmed-author:HylandR HRH,
pubmed-author:KennedyS JSJ,
pubmed-author:KorzenikJJ,
pubmed-author:MarraU DUD,
pubmed-author:McDonaldJJ,
pubmed-author:OzanneA PAP,
pubmed-author:PaldaV AVA,
pubmed-author:PiccirilloJ FJF,
pubmed-author:PicusDD,
pubmed-author:PlauchuHH,
pubmed-author:PorteousM E MME,
pubmed-author:ProctorD DDD,
pubmed-author:PyeritzR ERE,
pubmed-author:RossD ADA,
pubmed-author:SabbeGG,
pubmed-author:SpearsJJ,
pubmed-author:SwansonKK,
pubmed-author:TerryPP,
pubmed-author:WallachM HMH,
pubmed-author:WestermannC J JCJ,
pubmed-author:WhiteR IRI,
pubmed-author:YoungL HLH,
pubmed-author:ZarrabeitiaRR
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
48
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
73-87
|
|
pubmed:meshHeading |
pubmed-meshheading:19553198-Activin Receptors, Type II,
pubmed-meshheading:19553198-Adult,
pubmed-meshheading:19553198-Antigens, CD,
pubmed-meshheading:19553198-Child,
pubmed-meshheading:19553198-Early Detection of Cancer,
pubmed-meshheading:19553198-Epistaxis,
pubmed-meshheading:19553198-Gastrointestinal Hemorrhage,
pubmed-meshheading:19553198-Genetic Testing,
pubmed-meshheading:19553198-Humans,
pubmed-meshheading:19553198-Magnetic Resonance Imaging,
pubmed-meshheading:19553198-Mutation,
pubmed-meshheading:19553198-Receptors, Cell Surface,
pubmed-meshheading:19553198-Smad4 Protein,
pubmed-meshheading:19553198-Telangiectasia, Hereditary Hemorrhagic,
pubmed-meshheading:19553198-Vascular Malformations
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia.
|
|
pubmed:affiliation |
Division of Respirology, Department of Medicine, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada. faughnanm@smh.ca
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Practice Guideline
|
